DBL Irinotecan Injection Concentrate 20mg/ml
Prescription Only
Drug type: Therapeutic
ATC code: L01XX19
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Route of administration: INTRAVENOUS
Active ingredient: Irinotecan hydrochloride trihydrate
Registrant
PFIZER PRIVATE LIMITED
Approval Date
2007-10-26
Approval Number
SIN13367P
Manufacturer
Zydus Hospira Oncology Private Limited
Licence Holder
PFIZER PRIVATE LIMITED